囊性纤维化慢性鼻窦炎的管理:一项基于证据的综述及推荐
该综述系统评价了囊性纤维化慢性鼻窦炎(CF CRS)管理的文献,涵盖鼻盐水、鼻内糖皮质激素、局部抗生素、CFTR调节剂治疗和内镜鼻窦手术五个主题,基于获益、危害和证据等级生成治疗推荐,结论为鼻盐水、内镜鼻窦手术和CFTR调节剂在适当情况下推荐使用,鼻内糖皮质激素和局部抗生素为可选方案。
要点
- 鼻盐水、内镜鼻窦手术和CFTR调节剂在适当情况下推荐用于CF CRS管理。
- 鼻内糖皮质激素和局部抗生素是CF CRS的治疗选项。
- 临床判断和经验在照护这一独特挑战性疾病患者中至关重要。
核心结论
- 基于当前可用证据,鼻盐水、内镜鼻窦手术和CFTR调节剂在适当情况下推荐用于CF CRS的管理。
- 鼻内糖皮质激素和局部抗生素是治疗选项。
- 临床判断和经验在照护这一独特挑战性疾病患者中至关重要。
研究设计与样本
- 本文为基于证据的综述及推荐(EBRR),对评估CF CRS管理干预的研究进行了系统文献综述。
- 采用符合EBRR指南的迭代审查流程,基于对获益、危害和总体证据等级的评估生成治疗推荐。
主要发现
- 共评价了5个独特主题的已发表文献:鼻盐水、鼻内糖皮质激素、局部抗生素、CFTR调节剂治疗和内镜鼻窦手术。
- 每个治疗类别均针对CF CRS患者的治疗结局进行了明确探究。
关键数值与推荐
- 鼻盐水、内镜鼻窦手术和CFTR调节剂在适当情况下推荐用于CF CRS的管理。
- 鼻内糖皮质激素和局部抗生素是CF CRS的治疗选项。
临床怎么用
- 基于当前可用证据,鼻盐水、内镜鼻窦手术和CFTR调节剂在适当情况下推荐用于CF CRS的管理。
- 鼻内糖皮质激素和局部抗生素是治疗选项。
- 临床判断和经验在照护这一独特挑战性疾病患者中至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cystic fibrosis (CF) chronic rhinosinusitis (CRS) has emerged as a distinct diagnostic entity, unique from other endotypes of CRS in its presentation, pathophysiology, diagnosis, treatment, and outcomes. As the sinonasal health of this patient population may have broad effects on pulmonary health and quality of life, a comprehensive understanding of the diagnostic and therapeutic approach to CF CRS is essential. In recognizing recent scientific advances and unique treatment modalities specific to this challenging patient population, in this review we systematically evaluate the scientific literature and provide an evidenced-based review with recommendations (EBRR) for fundamental management principles of CF CRS. METHODS: A systematic review of the literature was performed. Studies evaluating interventions for the management of CF CRS were included. An iterative review process was implemented in accordance with EBRR guidelines. A treatment recommendation was generated based on an assessment of the benefits, harms, and the overall grade of evidence. RESULTS: We evaluated the published literature on 5 unique topics. Each of the following therapeutic categories was investigated explicitly for treatment outcomes in patients with CF CRS: (1) nasal saline; (2) intranasal corticosteroids (INCS); (3) topical antibiotics; (4) cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy; and (5) endoscopic sinus surgery (ESS). CONCLUSION: Based on the currently available evidence, nasal saline, ESS, and CFTR modulators are recommended in the management of CF CRS when appropriate. INCS and topical antibiotics are options. Clinical judgment and experience are essential in caring for patients with this uniquely challenging disorder.
引用
- Spielman DB, Beswick DM, Kimple AJ, et al. The management of cystic fibrosis chronic rhinosinusitis: An evidenced-based review with recommendations. Int Forum Allergy Rhinol. 2022. PMID: 34933415. doi:10.1002/alr.22953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。